Cargando…

Poliovirus antibodies following two rounds of campaigns with a type 2 novel oral poliovirus vaccine in Liberia: a clustered, population-based seroprevalence survey

BACKGROUND: Novel oral poliovirus vaccine type 2 (nOPV2) was administered in Liberia in response to an outbreak of circulating vaccine-derived poliovirus type 2 (cVDPV2) in 2021. We conducted a serological survey of polio antibodies after two national campaigns with nOPV2. METHODS: This clustered, c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kennedy, Stephen B, Macklin, Grace R, Mason Ross, Gloria, Lopez Cavestany, Rocio, Moukom, Richelot A, Jones, Kathryn A V, Mainou, Bernardo A, Massaquoi, Moses B F, Kieh, Mark W S, Mach, Ondrej
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd 2023
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10187988/ https://www.ncbi.nlm.nih.gov/pubmed/37202026 http://dx.doi.org/10.1016/S2214-109X(23)00116-X

Ejemplares similares

Community-based survey to assess seroprevalence of poliovirus antibodies in far-north Cameroon in 2020
por: Claire Endegue, Marie, et al.
Publicado: (2022)

Achieving High Poliovirus Antibody Seroprevalence in Areas at Risk of Vaccine-Derived Poliovirus Transmission—Niger Experience
por: Ousmane, Sani, et al.
Publicado: (2021)

A Survey to Assess Serological Prevalence of Poliovirus Antibodies in Areas With High-Risk for Vaccine-Derived Poliovirus Transmission in Chad
por: Gamougam, Kadidja, et al.
Publicado: (2021)

Inactivated Poliovirus Vaccine Closing the Type 2 Immunity Gap in Vietnam
por: Huyen, Dang Thi Thanh, et al.
Publicado: (2022)

Assessment of poliovirus antibody seroprevalence in high risk areas for vaccine derived poliovirus transmission in Madagascar
por: Razafindratsimandresy, Richter, et al.
Publicado: (2018)

Review of use of inactivated poliovirus vaccine in campaigns to control type 2 circulating vaccine derived poliovirus (cVDPV) outbreaks()
por: Estivariz, Concepcion F., et al.
Publicado: (2023)

Poliovirus seroprevalence before and after interruption of poliovirus transmission in Kano State, Nigeria
por: Iliyasu, Zubairu, et al.
Publicado: (2016)

Achieving high immunogenicity against poliovirus with fractional doses of inactivated poliovirus vaccine in Ecuador-results from a cross-sectional serological survey
por: Trueba, Gabriel, et al.
Publicado: (2022)

Does Simultaneous Administration of Bivalent (Types 1 and 3) Oral Poliovirus Vaccine and Inactivated Poliovirus Vaccine Induce Mucosal Cross-immunity to Poliovirus Type 2?
por: Resik, Sonia, et al.
Publicado: (2018)

Achieving high seroprevalence against polioviruses in Sri Lanka-Results from a serological survey, 2014
por: Gamage, Deepa, et al.
Publicado: (2015)

Trends in Poliovirus Seroprevalence in Kano State, Northern Nigeria
por: Verma, Harish, et al.
Publicado: (2018)

One Full or Two Fractional Doses of Inactivated Poliovirus Vaccine for Catch-up Vaccination in Older Infants: A Randomized Clinical Trial in Bangladesh( )
por: Aziz, Asma B, et al.
Publicado: (2022)

Effect of Inactivated Poliovirus Vaccine Campaigns, Pakistan, 2014–2017
por: Grassly, Nicholas C., et al.
Publicado: (2018)

Update on Immunodeficiency-Associated Vaccine-Derived Polioviruses — Worldwide, July 2018–December 2019
por: Macklin, Grace, et al.
Publicado: (2020)

Prolonged Excretion of Poliovirus among Individuals with Primary Immunodeficiency Disorder: An Analysis of the World Health Organization Registry
por: Macklin, Grace, et al.
Publicado: (2017)

Mucosal immunity to poliovirus
por: Connor, Ruth I., et al.
Publicado: (2021)

Seroprevalence of Poliovirus Antibodies in the United States Population, 2009–2010
por: Wallace, Gregory S., et al.
Publicado: (2016)

Assessment of seroprevalence against poliovirus among Italian adolescents and adults
por: Lupi, Silvia, et al.
Publicado: (2018)

Direct detection of polioviruses using a recombinant poliovirus receptor
por: Gerloff, Nancy, et al.
Publicado: (2021)

Fractional-Dose Inactivated Poliovirus Vaccine Campaign — Sindh Province, Pakistan, 2016
por: Pervaiz, Aslam, et al.
Publicado: (2017)

Feasibility of conducting intradermal vaccination campaign with inactivated poliovirus vaccine using Tropis intradermal needle free injection system, Karachi, Pakistan
por: Yousafzai, Mohammad Tahir, et al.
Publicado: (2017)

Poliovirus excretion following vaccination with live poliovirus vaccine in patients with primary immunodeficiency disorders: clinicians’ perspectives in the endgame plan for polio eradication
por: Galal, Nermeen M., et al.
Publicado: (2018)

Decay of Sabin inactivated poliovirus vaccine (IPV)-boosted poliovirus antibodies
por: Resik, Sonia, et al.
Publicado: (2015)

The effect of maternal poliovirus antibodies on the immune responses of infants to poliovirus vaccines
por: Jia, Siyue, et al.
Publicado: (2020)

Seroprevalence rate of Poliovirus antibodies among the Healthy and Protein Energy Malnutrition children
por: Yousuf, Aliya, et al.
Publicado: (2015)

Group effort from poliovirus
por: Wells, William A.
Publicado: (2006)

Revealing the Poliovirus’s Path to Infection
por: Gross, Liza
Publicado: (2007)

The Case for Live Poliovirus Vaccination
por: Paul, John R.
Publicado: (1960)

Molecular aspects of poliovirus pathogenesis
por: Nomoto, Akio
Publicado: (2007)

Comparative epidemiology of poliovirus transmission
por: Noori, Navideh, et al.
Publicado: (2017)

The mechanism of RNA recombination in poliovirus
por: Kirkegaard, Karla, et al.
Publicado: (1986)

The Fight against Poliovirus Is Not Over
por: Mbani, Chaldam Jespère, et al.
Publicado: (2023)

Managing the risk of circulating vaccine-derived poliovirus during the endgame: oral poliovirus vaccine needs
por: Duintjer Tebbens, Radboud J., et al.
Publicado: (2015)

Intradermal administration of fractional doses of the inactivated poliovirus vaccine in a campaign: a pragmatic, open-label, non-inferiority trial in The Gambia
por: Bashorun, Adedapo O, et al.
Publicado: (2021)

Is Italian population protected from Poliovirus? Results of a seroprevalence survey in Florence, Italy
por: Giammanco, Giovanni M., et al.
Publicado: (2018)

Recombination between Polioviruses and Co-Circulating Coxsackie A Viruses: Role in the Emergence of Pathogenic Vaccine-Derived Polioviruses
por: Jegouic, Sophie, et al.
Publicado: (2009)

Estimated Effect of Inactivated Poliovirus Vaccine Campaigns, Nigeria and Pakistan, January 2014–April 2016
por: Shirreff, George, et al.
Publicado: (2017)

Rapid emergence and transmission of virulence-associated mutations in the oral poliovirus vaccine following vaccination campaigns
por: Walter, Katharine S., et al.
Publicado: (2023)

Rapid emergence and transmission of virulence-associated mutations in the oral poliovirus vaccine following vaccination campaigns
por: Walter, Katharine S., et al.
Publicado: (2023)

The impact of surveillance and other factors on detection of emergent and circulating vaccine derived polioviruses
por: Auzenbergs, Megan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ilpgs2ssag4dejsf456kne8ttp